Skip to main content
Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
62.26
+0.48 (0.78%)
At close: May 31, 2024, 4:00 PM
62.20
-0.06 (-0.10%)
After-hours: May 31, 2024, 7:56 PM EDT

Viking Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
6.87B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.32B
The Ensign Group 3.85B
Jazz Pharmaceuticals 3.84B
Masimo 1.98B
Penumbra 1.10B
HealthEquity 999.59M
Intra-Cellular Therapies 513.93M
Blueprint Medicines 282.21M
Revenue Rankings

VKTX News

More News